Dear Editor: I read with great interest the article by Correll et al,1 titled, “Literary Prescriptions: Applying Bibliotherapy in a Psychotherapeutic Context,” published in Innovations in Clinical Neuroscience. The authors
Dear Editor: We thank Dr. Siamian for the thoughtful commentary on our article, “Literary Prescriptions: Applying Bibliotherapy in a Psychotherapeutic Context.”1 The letter addresses important questions about how bibliotherapy is
Innov Clin Neurosci. 2026;23(7–9):7–18. Mahdiyeh Hedayati-Moghadam, PhD; Fatemeh Seyedi, PhD; Habibeh Mashayekhi-Sardoo, PhD; Faezeh Mirzaee, MD; Mohammad Dalfardi, MSc; and Yousef Baghcheghi, PhD Dr. Hedayati-Moghadam is with the Department of
Innov Clin Neurosci. 2026;23(7–9):19–23. David Klopfer, MD; William Jeffrey, PT, DPT; Lara Shoukair, MD; and Nita V. Bhatt, MD, MPH Drs. Klopfer, Jeffrey, Shoukair, and Bhatt are with the Wright
Innov Clin Neurosci. 2026;23(7–9):24–26. Jeremiah Hsu, MD; Mahaksh Kotdawala, MD; and Thomas Priolo, MD Dr. Hsu is with Hackensack Meridian Health, Ocean University Medical Center, Brick Township, New Jersey. Drs.
Innov Clin Neurosci. 2026;23(7–9):27–31. Hira Liaqat, PhD; Saima Dawood, PhD; and Neelofar Rehman, PhD Drs. Liaqat and Dawood are with the Centre for Clinical Psychology, University of the Punjab, Lahore,
Innov Clin Neurosci. 2026;23(7–9):32–33. Özlem Totuk, MD, and Sevki Sahin, MD Dr. Totuk is with Sancaktepe Şehit Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul, Turkey. Dr. Sahin is
Innov Clin Neurosci. 2026;23(7–9):34–42. Manish Tyagi, MD; Ajay Kumar, MD; Sanjeev Kumar Jain, MD; Sonika Sharma, PhD; and Shehzeen Afag, PhD All authors are with Teerthanker Mahaveer University, Moradabad, India.
Innov Clin Neurosci. 2026;23(7–9):43–45. Çağrı Yenigün, MD, and Çiçek Hocaoğlu, MD Drs. Yenigün and Hocaoğlu are with the Recep Tayyip Erdoğan University Faculty of Medicine, Department of Psychiatry. FUNDING: No
Innov Clin Neurosci. 2026;23(7–9):46–47. Denita Neal, JD Ms. Neal is Senior Risk Manager, Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation of this article. DISCLOSURES:
Innov Clin Neurosci. 2026;23(1–3):47–53. by Hamed Zarei, MD*; Mohammadhossein Vazirizadeh-Mahabadi, MD*; Narges Saadatipour, MD; Maryam Pazhooha, MD; Mostafa Hosseini, PhD; and Mahmoud Yousefifard, PhD *Drs. Zarei and Vazirizadeh-Mahabadi contributed equally
by Justin Pope, JD Mr. Pope is Associate Director of Risk Management at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation of this article. DISCLOSURES:
Innov Clin Neurosci. 2025;22(7–9):42–43. by Akemini “Kem” Isang, RN, JD Ms. Isang is a Risk Manager at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation
by Eirini Beneki, MD, MSc, PhD; Kyriakos Dimitriadis, MD, PhD; Konstantinos Tsatiris, MD, MSc; Konstantina Aggeli, MD, PhD; and Konstantinos Tsioufis, MD, PhD Drs. Beneki, Dimitriadis, Aggeli, and Tsioufis are
by Atmaram Yarlagadda, MD; Kevin Swift, PhD; Nabarun Chakraborty, MS, MBA; Rasha Hammamieh, PhD; Amina Abubakar, PharmD; Marianna Wilbur, PharmD; and Anita H. Clayton, MD Dr. Yarlagadda is Installation Director
by Samara White, PharmD; Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP; Eileen Trigoboff, PMHCNS-BC, DNS, DABFN; Lucy Keers, PharmD; and Chloe Matecki, PharmD All authors are with Department of
by Yael Marks, BS, PharmD; Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP; and Chloe Matecki, PharmD All authors are with Department of Pharmacy Practice, State University of New York
by Sydnee Akubuiro, MD; Wendy Clay, MPH, MD; Suzie Nelson, MD; and Allison E. Cowan, MD Dr. Akubuiro is with Department of Psychiatry and Behavioral Sciences, Emory University School of
by Joana Jesus-Ribeiro, PhD; Luís Miguel Pires, MS; Ilda Patrícia Ribeiro, PhD; Olinda Rebelo, MD; Ricardo Pereira, MD; Francisco Sales, MD; Isabel Santana, PhD; António Freire, PhD; and Joana Barbosa
by Donna Vanderpool, MBA, JD Ms. Vanderpool is Director of Risk Management at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures:
